UCN-01 and Irinotecan in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple-Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

This study is ongoing, but not recruiting participants.

Study NCT00031681 Information provided by National Cancer Institute (NCI)

First Received: March 8, 2002 Last Updated: February 22, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	July 2002 (Final data collection date for primary outcome measure)